Omics Tools, MDx Stocks Rise with Biotech Surge in September | GenomeWeb

NEW YORK (GenomeWeb News) – Stocks for 'omics tools and molecular diagnostics firms climbed in September amid a general upswing for biotech stocks.

Among the 30 firms that comprise the GenomeWeb Daily News Index, only four saw a decline in their share price over the course of the month, and not a single stock was down in the double digits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.